A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Labor ministry updates rules expanding shutdowns after work accidents
07/08/2025 11:01 PM - Business
Taiwan's consumer price index eases to 1.37%, a 4-year low: DGBAS
07/08/2025 10:36 PM - Society
2 dead after dinghy capsizes in New Taipei rescue mission
07/08/2025 10:12 PM - Business
Taiwan's exports rise for 20th straight month to new high in June
07/08/2025 09:53 PM - Cross-Strait
CAA addresses Chinese civilian plane flying over Kinmen
07/08/2025 09:27 PM